<?xml version="1.0" encoding="UTF-8"?>
<p>Early neuroleptic agents showed great antipsychotic promise initially, however, the induction of extrapyramidal side effects associated with their use constituted a significant problem. Atypical antipsychotics possess a lower extrapyramidal side effects liability and show a better efficacy in the treatment of negative and depressive symptoms as well as cognitive disorders associated with schizophrenia. These features have been related to a higher affinity to serotonin receptors. However, they brought about various side effects such as weight gain, hyperglycemia, cholesterol level elevation, and QT interval prolongation [
 <xref ref-type="bibr" rid="B14">14</xref>].
</p>
